UGM Develops COVID-19 'Breath Detector' with 97 Percent Accuracy Claim

24 September 2020 23:54 WIB

TEMPO.CO, Jakarta - Researchers from the Yogyakarta Gadjah Mada University (UGM) announced that it has developed a COVID-19 detector dubbed the “GeNose” that is claimed to be able to detect the virus through the subject’s breath.

The tool backed with artificial intelligence is said to be more efficient than the PCR swab tests and much more accurate than rapid test methods. It is supported by a centralized cloud computing to reach a real-time diagnosis. 

One of the UGM researchers involved in the GeNose project, Dian Kesumapramudya Nurputra, said it was created as a response to the increasing demand to do economic activities despite the pandemic.

“This is why we developed the GeNose that is quicker and more accurate,” said Nurputra in an online event that saw UGM handing over the technology to the research and development ministry. 

The GeNose works by detecting volatile organic compounds that contain the COVID-19 virus from a patient’s breath, and with the help of numerous sensors and artificial intelligence technology, will help decide whether a person’s breath contains the virus. 

The project was led by Kuwat Triyana from UGM’s Faculty of Math and Science (FMIPA), Ahmad Kusumaatmaja (FMIPA), Ahmad Kusumaatmaja (FMIPA), and Mohamad Saifudin Hakim (FKKMK). 

The research’s leader Kuwat said the detector was already tested on 600 valid samples obtained from Yogyakarta’s Bhayangkara Hospital and Bambanglipuro Hospital and claimed that it has 97 percent accuracy level. 

MOH KHORY ALFARIZI



Covid-19 Pandemic Could Soon End, Says President Jokowi

2 hari lalu

Covid-19 Pandemic Could Soon End, Says President Jokowi

Jokowi hinted at the possibility that the government will announce the end of the Covid-19 pandemic.


Jakarta the Highest Contributor of Covid-19 Positive Cases Today: Health Ministry

3 hari lalu

Jakarta the Highest Contributor of Covid-19 Positive Cases Today: Health Ministry

The number of positive confirmed cases of COVID-19 on Sunday, October 2, 2022, increased by 1,322 cases with Jakarta contributed the highest number.


Taiwan to End COVID-19 Quarantine for Arrivals, Welcome Back Tourists

6 hari lalu

Taiwan to End COVID-19 Quarantine for Arrivals, Welcome Back Tourists

Taiwan says arrivals will still need to monitor their health for a seven-day period and take rapid tests, but tourists will be allowed to return.


Jokowi Will Not Follow Joe Biden and Declare 'Pandemic is Over'

16 hari lalu

Jokowi Will Not Follow Joe Biden and Declare 'Pandemic is Over'

Jokowi prefers to wait for a decision from the World Health Organization (WHO).


Malaysia Urges ASEAN to Speed Up Post-pandemic Recovery Initiatives

21 hari lalu

Malaysia Urges ASEAN to Speed Up Post-pandemic Recovery Initiatives

ASEAN must speed up the initiatives under the ASEAN Comprehensive Recovery Framework (ACRF) to face rising uncertainties in the current global economy


IDI Encourages Booster Vaccination to Reach Endemic Level

22 hari lalu

IDI Encourages Booster Vaccination to Reach Endemic Level

The COVID-19 Task Force Head of the Indonesian Medical Association (IDI), Erlina Burhan, encourages the public to immediately get booster shots.


Indonesia Adds New 1,848 COVID-19 Cases

23 hari lalu

Indonesia Adds New 1,848 COVID-19 Cases

The COVID-19 Handling Task Force recorded an additional 1,848 COVID-19 infections as of 12 p.m. local time on Monday


All Indonesia Regions at PPKM Level 1

30 hari lalu

All Indonesia Regions at PPKM Level 1

The government has announced that all regions of Indonesia are under the public activity restriction or PPKM level 1.


Global COVID-19 Cases Surpass 600 Mn: WHO

34 hari lalu

Global COVID-19 Cases Surpass 600 Mn: WHO

The number of COVID-19 cases worldwide has surpassed 600 million, according to the latest data from the World Health Organization (WHO).


BPOM in Process of Approving Sinovac Doses for Children Aged 3

36 hari lalu

BPOM in Process of Approving Sinovac Doses for Children Aged 3

BPOM is processing the emergency use authorization (EUA) for the primary dose of the Covid-19 Sinovac vaccine for children aged 3 and above.